http://www.washingtonwatch.com/bills info@washingtonwatch.com http://www.pjdoland.com/chai/?v=0.1 http://www.washingtonwatch.com/bills/history/110_HR_3011.html?rev=30931 <p>H.R. 3011 would amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.</p> <h2 id="toc0"> Detailed Summary </h2> <p>Amends title XVIII (Medicare) of the Social Security Act to revise the average sales price methodology for payment for drugs and biologicals under Medicare part B (Supplementary Medical Insurance Benefits for Aged and Disabled). Directs the Secretary of Health and Human Services to increase the payment amount for a drug or biological to the extent necessary to ensure that it is in no case less than the widely available market price.</p> <p>Limits the prompt pay discounts included in the calculation of the manufacturer's average sales price to those discounts furnished to physicians. Excludes such discounts from the average sales price calculation for years after 2004.</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc1"> Status of the Legislation </h2> <p>Latest Major Action: 7/17/2007: Referred to House subcommittee. Status: Referred to the Subcommittee on Health.</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc2"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc3"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 30931@http://www.washingtonwatch.com Tue, 16 Sep 2008 00:00:00 EDT http://www.washingtonwatch.com/bills/history/110_HR_3011.html?rev=4774 <p>H.R. 3011 would amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.</p> <h2 id="toc4"> Detailed Summary </h2> <p>Amends title XVIII (Medicare) of the Social Security Act to revise the average sales price methodology for payment for drugs and biologicals under Medicare part B (Supplementary Medical Insurance Benefits for Aged and Disabled). Directs the Secretary of Health and Human Services to increase the payment amount for a drug or biological to the extent necessary to ensure that it is in no case less than the widely available market price.</p> <p>Limits the prompt pay discounts included in the calculation of the manufacturer's average sales price to those discounts furnished to physicians. Excludes such discounts from the average sales price calculation for years after 2004.</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc5"> Status of the Legislation </h2> <p>Latest Major Action: 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc6"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc7"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 4774@http://www.washingtonwatch.com Thu, 19 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/show/110_HR_3011.html 7/17/2007: Referred to House subcommittee. Status: Referred to the Subcommittee on Health. 39695@http://www.washingtonwatch.com Tue, 17 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/history/110_HR_3011.html?rev=4287 <p>H.R. 3011 would amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.</p> <h2 id="toc8"> Detailed Summary </h2> <p>(Log in to edit the wiki and be the first to provide a detailed summary of the bill!)</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc9"> Status of the Legislation </h2> <p>(Log in to edit the wiki and be the first to update the status of the bill!)</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc10"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc11"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 4287@http://www.washingtonwatch.com Fri, 13 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/history/110_HR_3011.html?rev=4288 <p>H.R. 3011 would amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.</p> <h2 id="toc12"> Detailed Summary </h2> <p>(Log in to edit the wiki and be the first to provide a detailed summary of the bill!)</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc13"> Status of the Legislation </h2> <p>Latest Major Action: 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc14"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc15"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 4288@http://www.washingtonwatch.com Fri, 13 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/show/110_HR_3011.html 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 23539@http://www.washingtonwatch.com Thu, 12 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/show/110_HR_3011.html 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 28783@http://www.washingtonwatch.com Thu, 12 Jul 2007 00:00:00 EDT